Green Cross Labcell starts world’s first commercialization of NK cell treatment
An anticancer therapy, which uses other healthy people’s immune cells not the ones of cancer patients, is expected to be commercialized within in a couple of years for the first time in the world.
On the 13th, Green Cross Labcell(President Bok-soo Park), a family company of Green Cross in the fi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
